Form 8-K - Current report:
SEC Accession No. 0000950170-25-016390
Filing Date
2025-02-07
Accepted
2025-02-07 16:45:08
Documents
11
Period of Report
2025-02-05
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20250205.htm   iXBRL 8-K 45858
  Complete submission text file 0000950170-25-016390.txt   160263

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20250205.xsd EX-101.SCH 24849
13 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20250205_htm.xml XML 4700
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 25602554
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)